EZH2 and breast carcinoma: The significance of the overexpression of EZH2 and ITGA11 in cancer progression and aggressiveness was also confirmed in breast cancer patients, using Kaplan-Meier survival analysis on The Cancer Genome Atlas (TCGA) dataset.